These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27069125)

  • 1. Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2'-deoxyguanosine and Nitrotyrosine in Melanoma.
    Hintsala HR; Jokinen E; Haapasaari KM; Moza M; Ristimäki A; Soini Y; Koivunen J; Karihtala P
    Anticancer Res; 2016 Apr; 36(4):1497-506. PubMed ID: 27069125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma.
    Hintsala HR; Haapasaari KM; Soini Y; Karihtala P
    Histol Histopathol; 2017 Feb; 32(2):129-136. PubMed ID: 27170270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
    Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
    Soini Y; Haapasaari KM; Vaarala MH; Turpeenniemi-Hujanen T; Kärjä V; Karihtala P
    Int J Clin Exp Pathol; 2011 Mar; 4(3):267-75. PubMed ID: 21487522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
    Isohookana J; Haapasaari KM; Soini Y; Karihtala P
    Diagn Pathol; 2015 Apr; 10():28. PubMed ID: 25879528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas.
    Karihtala P; Kauppila S; Soini Y; Arja-Jukkola-Vuorinen
    BMC Cancer; 2011 Jun; 11():262. PubMed ID: 21693047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
    Chen CS; Tseng YT; Hsu YY; Lo YC
    Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAM129B-dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells.
    Schmidlin CJ; Tian W; Dodson M; Chapman E; Zhang DD
    Mol Carcinog; 2021 May; 60(5):331-341. PubMed ID: 33684228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Nrf2 in oxidative stress-induced endothelial injuries.
    Chen B; Lu Y; Chen Y; Cheng J
    J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the Nrf2-Keap1 signaling pathway and its downstream target genes in rat brain under stress.
    Djordjevic J; Djordjevic A; Adzic M; Mitic M; Lukic I; Radojcic MB
    Brain Res; 2015 Mar; 1602():20-31. PubMed ID: 25598205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of Keap1-Nrf2 pathway expression after experimental intracerebral haemorrhage: correlation with brain oedema and neurological deficit.
    Shang H; Yang D; Zhang W; Li T; Ren X; Wang X; Zhao W
    Free Radic Res; 2013 May; 47(5):368-75. PubMed ID: 23438812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keap1-Nrf2 signalling in pancreatic cancer.
    Hayes AJ; Skouras C; Haugk B; Charnley RM
    Int J Biochem Cell Biol; 2015 Aug; 65():288-99. PubMed ID: 26117456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.
    Murtas D; Piras F; Minerba L; Ugalde J; Floris C; Maxia C; Demurtas P; Perra MT; Sirigu P
    Oncol Rep; 2010 Feb; 23(2):329-35. PubMed ID: 20043092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
    Yang SP; Yang XZ; Cao GP
    Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of 8-OHdG and PARK7/DJ-1 in peri-implantitis mucosa.
    Kasnak G; Firatli E; Könönen E; Olgac V; Zeidán-Chuliá F; Gursoy UK
    Clin Implant Dent Relat Res; 2018 Aug; 20(4):574-582. PubMed ID: 29787640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
    Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
    Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward clinical application of the Keap1-Nrf2 pathway.
    Suzuki T; Motohashi H; Yamamoto M
    Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and Nrf2 signaling in McArdle disease.
    Kitaoka Y; Ogborn DI; Nilsson MI; Mocellin NJ; MacNeil LG; Tarnopolsky MA
    Mol Genet Metab; 2013 Nov; 110(3):297-302. PubMed ID: 23906480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.